CSIMarket Company Name, Ticker, Suppliers, else..
 
United Health Products Inc   (UEEC)
Other Ticker:  
 
 
Price: $0.0560 $0.00 -4.274%
Day's High: $0.0585 Week Perf: -5.08 %
Day's Low: $ 0.05 30 Day Perf: -16.42 %
Volume (M): 99 52 Wk High: $ 0.26
Volume (M$): $ 6 52 Wk Avg: $0.15
Open: $0.06 52 Wk Low: $0.05



 Market Capitalization (Millions $) 14
 Shares Outstanding (Millions) 249
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -2
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

United Health Products Inc
United Health Products Inc is a company that specializes in the design, production, and distribution of healthcare products. They primarily focus on manufacturing hemostatic gauze called HemoStyp, which is used to control bleeding during surgical procedures or in emergency situations. The company aims to provide innovative and effective solutions for medical professionals and patients to improve healthcare outcomes. United Health Products Inc is committed to using advanced technologies and research to contribute to the medical field, with a focus on safety and quality.


   Company Address: 520 Fellowship Road Mt. Laurel 8054 NJ
   Company Phone Number: 755-1005   Stock Exchange / Ticker: UEEC


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
MMM        4.78% 
PSTV        2.63% 
• View Complete Report
   



Product Service News

United Health Products Updates Stakeholders on FDA Premarket Approval for Key Medical Product

Published Mon, Nov 4 2024 1:01 PM UTC

Mount Laurel, N.J. On November 4, 2024, United Health Products, Inc. (OTCPK: UEEC) issued a formal update concerning its ongoing Premarket Approval (PMA) application with the U.S. Food and Drug Administration (FDA). The company, recognized for its innovations in the healthcare sector, particularly in wound management, has been navigating this crucial regulatory pathway to ...
United Health Products Inc

UEEC Reports Significant Gain for Investors Despite Operating Deficit of $-0.425094 Million

As the fiscal earnings cycle for January to March 31, 2024 unfolds, various corporations are releasing their respective results. This includes several companies within the Medical Equipment & Supplies industry. One such company, UEEC, recently announced an operating deficit of -$0.425094 million for the three-month period ending on March 31, 2024. While this operating deficit represents an improvement over the first quarter of 2023, where the deficit stood at -$1.053975 million, it is still an important indicator for the company's trajectory.
For companies like UEEC that are in the growth phase, it is crucial to operate efficiently in order to progress to the next level. However, it is worth noting that there has been some mitigation of the deficit compared to the previous year. The deficit for the most recent fiscal period stood at -$0.452 million, whereas it was -$1.143 million in the first quarter of 2023.
United Health Products Inc

United Health Products Inc. Shows Progress with Decrease in Operating Loss in Q4 2023

As a financial analyst for the , I have closely examined the latest financial results of United Health Products Inc. and it is clear that investors did not receive the news they were hoping for in the October to December 31 2023 reporting cycle. The medical equipment and supplies company posted an operating loss of $-0.446657 million, a slight improvement from the previous year's $-0.553563 million loss.
While the numbers may not be as positive as some investors had hoped, it is important to note that United Health Products Inc is still in the early stages of developing its business model. The fact that the company was able to decrease its operating loss from the previous year is a promising sign of progress. It is crucial for emerging companies like UEEC to operate efficiently in order to move on to the next phase of growth.
United Health Products Inc

United Health Products Inc. Records Remarkable Growth with a Whopping Top-line of $0 Million in Q3 of 2023



United Health Products Inc (UEEC) recently released its financial results for the third quarter of 2023, revealing a stagnation in gains per share and a decline in revenue compared to the same period last year. The company's net shortfall of $-0.486 million further raises doubts about its future prospects. This article delves into the significance of these financial outcomes and explores their potential impact on United Health Products Inc in the coming years.
Zero Gain per Share:
For the third quarter of 2023, United Health Products Inc reported a zero gain of $0.00 per share. This figure remained unchanged from the previous year and the preceding quarter. From an investor's standpoint, this lack of growth is concerning, as it indicates a lack of profit generation and potential failure to meet market expectations. The absence of any substantial positive movement suggests that the company's strategies to increase profitability have not yet yielded significant results.
United Health Products Inc

United Health Products Inc hit with financial storm as operating deficit plummets to -$0.475456 million, rattling investors


Introduction
The second quarter results of 2023 have left industry observers and investors concerned about the future of United Health Products Inc. Despite the company's efforts to improve its business model and decrease losses, the operating deficit for the quarter was a staggering $-0.475456 million. This lack of revenue has raised doubts about the company's ability to maintain a stable position in the Medical Equipment & Supplies sector. Furthermore, the recent decline in United Health Products Inc stock has only exacerbated concerns, with a drastic -11.67% decrease in the past 5 trading days and a year-to-date performance of 0%. Let's delve into the underlying issues affecting the company's prospects.
Operational Challenges
United Health Products Inc failed to generate any significant revenue during the April to June 2023 reporting season. This absence of revenue is particularly alarming given the intense scrutiny on the company's financial performance. The operating deficit of $-0.475456 million highlights the struggles the company is facing in maintaining a profitable business model. With such a substantial operating deficit, United Health Products Inc's ability to sustain itself in the coming months becomes highly questionable.









Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com